1. Recombinant protein expression and purification 1.1. p97. E. coli BL21 (DE3) cells containing plasmid pET14b-p97 were grown in Luria Broth (LB) medium containing 100 µg/mL ampicillin at 37°C to an OD 600 of 0.8, followed by induction with 0.5 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) for 4 h at 37°C.
Cells were collected by centrifugation (3000 × g for 10 min), resuspended in 40 mL lysis buffer (50 mM HEPES, pH 7.4, 150 mM KCl, 5 mM MgCl 2 , 5% glycerol, 2 mM β-mercaptoethanol (BME), one complete EDTA-free protease inhibitor cocktail per 50 mL of buffer (Roche)), and lysed by single passage through an M110-T microfluidizer (Microfluidics). The lysate was clarified by centrifugation (118,834 × g, 1 h, 4°C) and the resulting supernatant was incubated for 1 h at 4°C with Talon Metal Affinity Resin (Clontech) in 50 mM HEPES, pH 7.4, 150 mM KCl, 5 mM MgCl 2 , 5% glycerol. The resin and supernatant were then loaded into a 25 mL disposable column (Biorad), washed with 10 column volumes of wash buffer (50 mM HEPES, pH 7.4, 150 mM KCl, 5 mM MgCl 2 , 5% glycerol, 2 mM BME, 5 mM imidazole), followed by 10 column volumes of stringent wash buffer (50 mM HEPES, pH 7.4, 1M KCl, 5 mM MgCl 2 , 5% glycerol, 2 mM BME, 20mM imidazole), and eluted with elution buffer (50 mM HEPES, pH 7.4, 1M KCl, 5 mM MgCl 2 , 5% glycerol, 2 mM BME, 250mM imidazole). Fractions were analyzed by 12% SDS PAGE and those containing p97 were pooled and dialyzed into storage buffer (20 mM HEPES, 150 mM KCl, 5 mM MgCl 2 , 5% glycerol, 2 mM BME, pH 7.4), concentrated with an 30 kDa Ultra-15 centrifugal filter (Amicon) to yield a solution of pure p97 protein at 12 mg/mL, which was aliquoted, frozen in liquid nitrogen, and stored at -80°C until needed.
p97-Cys0.
Site directed mutagenesis was performed using wild type pET14b-p97 as a template. Ten out of 12 cysteine residues in p97 (C69, C77, C104, C174, C184, C415, C535, C572, C691, and C695) were mutated to valine and the remaining 2 cysteine residues (C209 and C522) were mutated to alanine using a modified quick change procedure that employs offset oligonucleotide harboring the desired mutation 1 .
All mutations were confirmed by DNA sequencing. Expression and purification of the p97-Cys0 construct was carried out as for wild-type p97.
1.3.p97-C522A. Site directed mutagenesis was performed using wild type pET14b-p97 as a template. A cysteine 522 residue was mutated to alanine and mutagenesis was carried out as for p97-Cys0 construct. A mutation was confirmed by DNA sequencing.
Expression and purification of p97-C522A was performed as for wild-type p97 then further purified through a Superose 6 10/300 GL preparative grade column (GE Healthcare) equilibrated with 20 mM HEPES pH 7.4, 150 mM KCl, 1 mM MgCl 2 , 5% glycerol, and 1 mM DTT. Fractions containing p97-C522A were pooled, snap frozen, and stored at -80°C until needed. 
